UK guidelines for Alzheimer’s emphasise good clinical practice Newsletter Article 09 February 2013 Pages: 2 - 2
‘Ground-breaking’ data on ‘real-world’ total costs of cancer treatment Carlene Todd Newsletter Article 09 February 2013 Pages: 3 - 4
Preventing opportunistic infections in patients with HIV Newsletter Article 09 February 2013 Pages: 5 - 5
Use of somatropin not justified in short stature and old age Newsletter Article 09 February 2013 Pages: 5 - 5
Controlled-release etodolac cost saving in osteoarthritis Newsletter Article 09 February 2013 Pages: 7 - 7
Economic burden of cerebrovascular disorders in the UK Newsletter Article 09 February 2013 Pages: 7 - 7
Fluvastatin for hypercholesterolaemia in managed-care setting Newsletter Article 09 February 2013 Pages: 8 - 8
DOT more cost effective than self administration in tuberculosis Newsletter Article 09 February 2013 Pages: 9 - 9
Lamivudine + zidovudine cost effective in HIV infection Newsletter Article 09 February 2013 Pages: 9 - 9
Calcium/colecalciferol prevents fractures and is cost effective Newsletter Article 09 February 2013 Pages: 10 - 10
Cost implications of end-stage liver disease without transplantation Newsletter Article 09 February 2013 Pages: 10 - 10
Prescribing policy the solution to Australia’s rising drug costs? Newsletter Article 09 February 2013 Pages: 11 - 11
New plan to abolish two-tier health system in the UK Newsletter Article 09 February 2013 Pages: 11 - 11
Should cost benefit be considered in vaccine coverage decisions? Newsletter Article 09 February 2013 Pages: 11 - 11
Campaign needed to increase use of medical records in France Newsletter Article 09 February 2013 Pages: 12 - 12